Authors:
Mendel, DB
Laird, AD
Smolich, BD
Blake, RA
Liang, CX
Hannah, AL
Shaheen, RM
Ellis, LM
Weitman, S
Shawver, LK
Cherrington, JM
Citation: Db. Mendel et al., Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent, ANTI-CAN DR, 15(1), 2000, pp. 29-41
Authors:
Laird, AD
Vajkoczy, P
Shawver, LK
Thurnher, A
Liang, C
Mohammadi, M
Schlessinger, J
Ullrich, A
Hubbard, SR
Blake, RA
Fong, TAT
Strawn, LM
Sun, L
Tang, C
Hawtin, R
Tang, F
Shenoy, N
Hirth, KP
McMahon, G
Cherrington, JM
Citation: Ad. Laird et al., SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors, CANCER RES, 60(15), 2000, pp. 4152-4160